Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis

Trial Profile

Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 Feb 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Triamcinolone (Primary)
  • Indications Uveitis
  • Focus Adverse reactions
  • Sponsors Clearside Biomedical
  • Most Recent Events

    • 10 Oct 2016 According to a Clearside Biomedical media release, results from the study will be presented at the Retina Sub-Specialty Day Meeting at the 2016 American Academy of Ophthalmology (AAO) Meeting.
    • 03 Aug 2016 According to a Clearside Biomedical media release, combined results from this and a phase II study (Profile 700249389) will be presented at the 2016 Annual Meeting of the American Society of Retina Specialists (ASRS).
    • 16 Mar 2015 According to Clearside Biomedical media release, status changed from active, no longer recruiting to completed.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top